Bionpharma Drug Patent Portfolio

Bionpharma owns 2 orange book drugs protected by 6 US patents Given below is the list of Bionpharma's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10022344 Liquid dosage forms of sodium naproxen 03 Mar, 2026
Active
US10028925 Liquid dosage forms of sodium naproxen 03 Mar, 2026
Active
US11090280 Liquid dosage forms of sodium naproxen 03 Mar, 2026
Active
US9693978 Solvent system for enhancing the solubility of pharmaceutical agents 03 Mar, 2026
Active
US9693979 Liquid dosage forms of sodium naproxen 03 Mar, 2026
Active
US6251426 Ibuprofen-containing softgels 25 Jun, 2018 Expired


Given below is the list of recent legal activities going on the following drug patents of Bionpharma.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 12 Jan, 2022 US10028925
Payment of Maintenance Fee, 4th Year, Large Entity 05 Jan, 2022 US10022344
Patent Issue Date Used in PTA Calculation 17 Aug, 2021 US11090280
Recordation of Patent Grant Mailed 17 Aug, 2021 US11090280
Email Notification 29 Jul, 2021 US11090280
Issue Notification Mailed 28 Jul, 2021 US11090280
Application Is Considered Ready for Issue 22 Jul, 2021 US11090280
Dispatch to FDC 22 Jul, 2021 US11090280
Response to Reasons for Allowance 13 Jul, 2021 US11090280
Issue Fee Payment Verified 13 Jul, 2021 US11090280
Issue Fee Payment Received 13 Jul, 2021 US11090280
Email Notification 30 Jun, 2021 US11090280
Mail Notice of Allowance 30 Jun, 2021 US11090280
Electronic Review 30 Jun, 2021 US11090280
Notice of Allowance Data Verification Completed 27 Jun, 2021 US11090280


Bionpharma's Drug Patent Litigations

Bionpharma's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jan 14, 2018, against patent number US9693979. The petitioner Catalent Pharma Solutions, Inc., challenged the validity of this patent, with Patheon Softgels Inc. as the respondent. Click below to track the latest information on how companies are challenging Bionpharma's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US11090280 July, 2020 Decision
(24 May, 2021)
PATHEON SOFTGELS INC
US9693978 January, 2018 Terminated-Denied
(13 Aug, 2018)
Patheon Softgels Inc. Catalent Pharma Solutions, Inc.
US9693979 January, 2018 Terminated-Denied
(13 Aug, 2018)
Patheon Softgels Inc. Catalent Pharma Solutions, Inc.


Bionpharma Drug Patents' Oppositions Filed in EPO

Bionpharma drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 14, 2017, by Dieckhoff, Beate. This opposition was filed on patent number EP06737018A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP06737018A Jun, 2017 Dieckhoff, Beate Patent maintained as amended


Bionpharma's Family Patents

Bionpharma drugs have patent protection in a total of 13 countries. It's US patent count contributes only to 39.1% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click below to unlock the full patent family tree.

Family Patents



Bionpharma Drug List

Given below is the complete list of Bionpharma's drugs and the patents protecting them.


1. Midol Liquid Gels

Midol Liquid Gels is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6251426 Ibuprofen-containing softgels 25 Jun, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Midol Liquid Gels's drug page


2. Naproxen Sodium

Naproxen Sodium is protected by 5 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10022344 Liquid dosage forms of sodium naproxen 03 Mar, 2026
(1 year, 4 months from now)
Active
US10028925 Liquid dosage forms of sodium naproxen 03 Mar, 2026
(1 year, 4 months from now)
Active
US11090280 Liquid dosage forms of sodium naproxen 03 Mar, 2026
(1 year, 4 months from now)
Active
US9693978 Solvent system for enhancing the solubility of pharmaceutical agents 03 Mar, 2026
(1 year, 4 months from now)
Active
US9693979 Liquid dosage forms of sodium naproxen 03 Mar, 2026
(1 year, 4 months from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Naproxen Sodium's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List